Department of Microbiology and Immunology, School of Medicine, China Medical University, Taichung, Taiwan.
Department of Medical Biotechnology and Laboratory science, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Microb Biotechnol. 2019 May;12(3):472-486. doi: 10.1111/1751-7915.13370. Epub 2019 Jan 31.
Klebsiella pneumoniae is an important human pathogen causing opportunistic nosocomial and community-acquired infections. A major public health concern regarding K. pneumoniae is the increasing incidence of multidrug-resistant strains. Here, we isolated three novel Klebsiella bacteriophages, KN1-1, KN3-1 and KN4-1, which infect KN1, KN3 and K56, and KN4 types respectively. We determined their genome sequences and conducted a comparative analysis that revealed a variable region containing capsule depolymerase-encoding genes. Recombinant depolymerase proteins were produced, and their enzymatic activity and specificity were evaluated. We identified four capsule depolymerases in these phages that could only digest the capsule types of their respective hosts. Our results demonstrate that the activities of these capsule depolymerases were correlated with the host range of each phage; thus, the capsule depolymerases are host specificity determinants. By generating a capsule mutant, we demonstrate that capsule was essential for phage adsorption and infection. Further, capsule depolymerases can enhance bacterial susceptibility to serum killing. The discovery of these phages and depolymerases lays the foundation for the typing of KN1, KN3, KN4 and K56 Klebsiella and could be useful alternative therapeutics for the treatment of K. pneumoniae infections.
肺炎克雷伯菌是一种重要的人类病原体,可引起机会性医院获得性和社区获得性感染。肺炎克雷伯菌越来越多的耐多药菌株是一个主要的公共卫生关注问题。在这里,我们分离到了三种新型的肺炎克雷伯菌噬菌体,分别命名为 KN1-1、KN3-1 和 KN4-1,它们分别感染 KN1、KN3 和 K56 以及 KN4 型。我们确定了它们的基因组序列,并进行了比较分析,揭示了一个包含荚膜降解酶编码基因的可变区。我们产生了重组的降解酶蛋白,并评估了它们的酶活性和特异性。我们在这些噬菌体中鉴定了四个荚膜降解酶,它们只能消化其各自宿主的荚膜类型。我们的结果表明,这些荚膜降解酶的活性与每种噬菌体的宿主范围相关;因此,荚膜降解酶是宿主特异性决定因素。通过生成荚膜突变体,我们证明荚膜对于噬菌体吸附和感染是必需的。此外,荚膜降解酶可以增强细菌对血清杀伤的敏感性。这些噬菌体和降解酶的发现为 KN1、KN3、KN4 和 K56 肺炎克雷伯菌的分型奠定了基础,并且可能是治疗肺炎克雷伯菌感染的有用替代疗法。